|
Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening
RECRUITINGN/ASponsored by M.D. Anderson Cancer Center
Actively Recruiting
PhaseN/A
SponsorM.D. Anderson Cancer Center
Started2023-10-30
Est. completion2028-08-31
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations2 sites
View on ClinicalTrials.gov →
NCT06109870
Summary
Cervical cancer is a disease that is preventable through vaccination against the virus that causes it, human papillomavirus (HPV), and through screening and treatment of cervical disease before it becomes cancet.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: To be eligible to participate in this study, an individual must meet all of the following criteria: * Provision of signed and dated informed consent form * Currently resident in RGV or other low-resource community in Texas * Stated willingness to comply with all study procedures * Females; Age ≥25 years * Have no history of hysterectomy with removal of the cervix * Have no history of cervical cancer or high-grade dysplasia * Have not had a Pap test in the past 3.5 years or Pap/HPV co-test in the past 5.5 years. Exclusion Criteria: An individual who meets any of the following criteria will be excluded from participation in this study: * Unable to communicate in English or Spanish * Lack valid telephone contact information * Report being currently pregnant.
Conditions2
CancerHPV
Locations2 sites
University of Texas at Austin
Austin, Texas, 78712
M D Anderson Cancer Center
Houston, Texas, 77030
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorM.D. Anderson Cancer Center
Started2023-10-30
Est. completion2028-08-31
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations2 sites
View on ClinicalTrials.gov →
NCT06109870